Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
29,980,270
-
Share change
-
+1,908,004
-
Total reported value
-
$1,138,926,248
-
Put/Call ratio
-
138%
-
Price per share
-
$37.99
-
Number of holders
-
165
-
Value change
-
+$111,838,910
-
Number of buys
-
90
-
Number of sells
-
64
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q4 2022
As of 31 Dec 2022,
REATA PHARMACEUTICALS INC - CL A (RETA) was held by
165 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,980,270 shares.
The largest 10 holders included
CPMG Inc, VANGUARD GROUP INC, BlackRock Inc., First Light Asset Management, LLC, FRED ALGER MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, DEUTSCHE BANK AG\, ADAGE CAPITAL PARTNERS GP, L.L.C., Boxer Capital, LLC, and Sofinnova Investments, Inc..
This page lists
165
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.